Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 27 December 1974:
Vol. 186. no. 4170, pp. 1223 - 1224
DOI: 10.1126/science.186.4170.1223
Prev | Table of Contents

Articles

beta-Adrenergic Receptor: Stereospecific Interaction of lodinated beta-Blocking Agent with High Affinity Site

G. D. Aurbach 1, S. A. Fedak 1, C. J. Woodard 1, J. S. Palmer 1, D. Hauser 1, and F. Troxler 2

1 Metabolic Diseases Branch, National Institute of Arthritis, Metabolism, and Digestive Diseases, Bethesda, Maryland 20014
2 Sandoz Limited, Basel, Switzerland

An iodine-labeled beta-adrenergic inhibitor (125l-hydroxybenzylpindolol) binds specifically to a site on turkey erythrocyte membranes. A series of beta-adrenergic agonists and inhibitors compete for this binding site, with apparent affinities paralleling biological effectiveness as activators or inhibitors of catecholaminestimulated adenylate cyclase. The activity of d-(+) agonists or inhibitors was 1 percent (or less) than that of the corresponding l-(-) isomers in competing for binding of the iodinated blocker as well as in affecting catecholamine-stimulated adenylate cyclase. 1-(-)-Norepinephrine was about one-tenth as active as l-(-)-isoproterenol in competing for the beta-blocking agent site. The stereospecificity of the interaction with the iodinated beta-blocking agent and the correspondence between affinity for site and biological potency of analogs suggested that this interaction is involved in function of the beta-adrenergic receptor.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
The Receptor Concept: A Continuing Evolution.
L. E. Limbird (2004)
Mol. Interv. 4, 326-336
   Abstract »    Full Text »    PDF »
G Proteins and Regulation of Adenylyl Cyclase.
A. G. Gilman (1989)
JAMA 262, 1819-1825
   Abstract »    PDF »
From epinephrine to cyclic AMP.
A Levitzki (1988)
Science 241, 800-806
   Abstract »    PDF »
Widespread distribution of brain dopamine receptors evidenced with [125I]iodosulpride, a highly selective ligand.
M. Martres, M. Bouthenet, N Sales, P Sokoloff, and J. Schwartz (1985)
Science 228, 752-755
   Abstract »    PDF »
Drug and neurotransmitter receptors in the brain.
S. Snyder (1984)
Science 224, 22-31
   Abstract »    PDF »
Catecholamine-induced alteration in sedimentation behavior of membrane bound beta-adrenergic receptors.
T. Harden, C. Cotton, G. Waldo, J. Lutton, and J. Perkins (1980)
Science 210, 441-443
   Abstract »    PDF »
Direct Binding Studies of Adrenergic Receptors: Biochemical, Physiologic, and Clinical Implications.
R. J. LEFKOWITZ (1979)
Ann Intern Med 91, 450-458
   Abstract »    PDF »
Hypersensitivity to Adrenergic Stimulation after Propranolol Withdrawal in Normal Subjects.
H. BOUDOULAS, R. P. LEWIS, R. E. KATES, and G. DALAMANGAS (1977)
Ann Intern Med 87, 433-436
   Abstract »    PDF »
beta-Adrenergic receptor involvement in 6-hydroxydopamine-induced supersensitivity in rat cerebral cortex.
J. Sporn, T. Harden, B. Wolfe, and P. Molinoff (1976)
Science 194, 624-626
   Abstract »    PDF »
Alpha-adrenergic receptor identification by (3H)dihydroergocryptine binding.
L. Williams and R. Lefkowitz (1976)
Science 192, 791-793
   Abstract »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)